Individuals carrying germline P/LP variants in the BRCA1 and BRCA2 genes have a cumulative lifetime risk of female breast cancer that is up to 80% and ovarian cancer risk up to 60% by age 80. This evidence concerns the gene BRCA2 and breast carcinoma.